Management of Arteriovenous Fistula in a 39-year Old Male Patient

Vertebral artery’s iatrogenic arteriovenous fistula due to central venous catheterization is an uncommon vascular complication. This report depicts a case of 21-year-old male patient who underwent central venous catheterization for hemodialysis over 10 years ago and was detected with a vertebrojugular arteriovenous fistula. This report depicts a case of 21-year-old male patient who detected with a vertebrojugular arteriovenous fistula after 10 years of hemodialysis through central venous catheterization. The surgical treatment was successfully performed.

Download Full-text

Conservative Approach in a 47-Year-Old Male Patient with Incidental Extensive Splenic Arteriovenous Fistula

Turkiye Klinikleri Journal of Case Reports ◽

10.5336/caserep.2018-61361 ◽

2018 ◽

Vol 26 (4) ◽

pp. 192-195

Author(s):

Recep Erçin SÖNMEZ ◽

Ali Fuat Kaan GÖK ◽

Aykhan ABBASOV ◽

Mehmet İLHAN ◽

Cemalettin ERTEKİN

Keyword(s):

Arteriovenous Fistula ◽

Male Patient ◽

Conservative Approach ◽

Splenic Arteriovenous Fistula

Download Full-text

Asystole during onyx embolisation of a dural AV fistula: The trigeminocardiac reflex

Interventional Neuroradiology ◽

10.1177/1591019918800801 ◽

2018 ◽

Vol 25 (2) ◽

pp. 132-134 ◽

Cited By ~ 2

Author(s):

Patrick Nicholson ◽

Christopher Hilditch ◽

Waleed Brinjikji ◽

Timo Krings

Keyword(s):

Skull Base ◽

Arteriovenous Fistula ◽

Male Patient ◽

Patient Experience ◽

Dural Arteriovenous Fistula ◽

Case Reports ◽

Neurosurgical Procedures ◽

Av Fistula ◽

Trigeminocardiac Reflex ◽

Onyx Embolisation

There are fewer than 20 published case reports of bradycardia or asystole during intracranial embolisation procedures. These are well described in open neurosurgical procedures, particularly involving the skull base. We present a case of a 59-year-old male patient who presented for elective embolisation of a dural arteriovenous fistula. During the injection of Onyx, the patient experience sudden asystole, which recurred after a second Onyx injection. Following successful treatment, a third injection proceeded without incident.

Download Full-text

Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma

American Journal of Audiology ◽

10.1044/2019_aja-18-0191 ◽

2019 ◽

Vol 28 (3) ◽

pp. 548-552

Author(s):

Andro Košec ◽

Ivan Kruljac ◽

Jakov Ajduk

Keyword(s):

Dopamine Receptors ◽

Male Patient ◽

Endolymphatic Hydrops ◽

Young Male ◽

Oral Steroid ◽

Case Description ◽

Diuretic Treatment ◽

Potential Therapeutic Role ◽

Transient Improvement ◽

Systemic Glucocorticoids

Objective Current recommendations for cochlear hydrops treatment include systemic glucocorticoids and diuretics. Cochlear cells express dopamine receptors, although their role is unknown in the pathophysiology of cochlear hydrops. Case Description We report the case of remission of recurrent right-sided cochlear hydrops in a young male patient treated with bromocriptine due to pituitary macroprolactinoma. Transient improvement was observed after oral steroid and diuretic treatment, but cochlear hydrops recurred until the dose of bromocriptine was increased to 10 mg daily. Conclusion Bromocriptine may stimulate dopamine receptors in cochlear cells with potential therapeutic role in patients with cochlear hydrops. There are no widely accepted and effective treatments for endolymphatic hydrops, and identifying potential new and efficacious therapeutics is of high relevance.

Download Full-text